CIK 1739426

RVL Pharmaceuticals plc

EDGAR filings

Customers

0 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Mar 31, 2021

10-Q filed 2021-05-13

Customers 1

Companies RVL Pharmaceuticals plc discloses as major customers, as a share of RVL Pharmaceuticals plc revenue. 0 active, 1 lapsed.

Company	% of RVL Pharmaceuticals plc revenue	Est. revenue	Period	Trend	Status	Source
MCK Distributor MCKESSON CORP	47%	$439.4K	3M 2021-03-31	+9.0pp	Lapsed Last seen 2021-03-31	10-Q 2021-05-13
McKesson 47 % 43 % 10-Q filed 2021-05-13 Period 3M 2021-01-01 to 2021-03-31 (47%), 3M 2020-01-01 to 2020-03-31 (43%)Accession 0001558370-21-007102 McKesson Corporation 43%; and AmerisourceBergen Corporation 31%. 10-K filed 2021-03-30 Period FY 2020-01-01 to 2020-12-31 (43%)Accession 0001558370-21-003726 McKesson 38 % 43 % 42 % 35 % 10-Q filed 2020-11-10 Period 3M 2020-07-01 to 2020-09-30 (38%), 3M 2019-07-01 to 2019-09-30 (43%)Accession 0001558370-20-013558 McKesson 42 % 31 % 43 % 33 % 10-Q filed 2020-08-11 Period 3M 2020-04-01 to 2020-06-30 (42%), 3M 2019-04-01 to 2019-06-30 (31%)Accession 0001558370-20-010320 McKesson 43 % 38 % 10-K filed 2021-03-30 Period FY 2019-01-01 to 2019-12-31 (38%)Accession 0001558370-21-003726 McKesson 43 % 36 % 10-Q filed 2020-05-12 Period 3M 2019-01-01 to 2019-03-31 (36%)Accession 0001558370-20-006425

Alerts are coming

Get an email when RVL Pharmaceuticals plc's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.